Fractional dosing of pneumococcal conjugate vaccine noninferior to full dosing schedule
1. In this randomized non-inferiority trial, 40% of a full dose of the 13-valent pneumococcal conjugate vaccine (PCV13) was noninferior ...
Tag: vaccine
#VisualAbstract Tetravalent Protein COVID-19 Vaccine SCTV01E Reduces Risk of COVID-19 Infectious for up to 98 Days
Click here to read this study in Nature Communications. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Merck’s Capvaxive Seeks to Become the Primary Shot for Pneumococcal Disease Prevention
Capvaxive covers roughly 84% of serotypes responsible for pneumococcal disease in adults 50 years and older. Capvaxive is non-inferior to ...
Valneva Gears Up To Launch The First Ever Chikungunya Virus Vaccine
Ixchiq is a single shot live attenuated vaccine for the prevention of chikungunya virus vaccine which provided immunity to over ...
R21/Matrix-M vaccine offers significant protection against malaria in African children
1. The R21/Matrix-M vaccine had a high 12-month efficacy across seasonal and standard sites. 2. The reduction in malarial infection ...
#VisualAbstract: RSV Prefusion F Protein-Based Maternal Vaccine Lowers Risk of Infant RSV Infection but Increases the Risk of Preterm Birth
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No ...
#VisualAbstract: Butantan-Dengue Vaccine effective in preventing symptomatic dengue
1. In this randomized controlled trial, the Butantan-Dengue Vaccine (Butantan-DV) was effective in the prevention of symptomatic, virologically confirmed dengue ...
The 2 Minute Medicine Podcast Episode 34
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
#VisualAbstract: High-Dose Recombinant Influenza Vaccine is More Effective than Standard-Dose Vaccine in Adults Aged 50 to 64 Years
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed ...
Effectiveness of the live zoster vaccine during the 10 years following vaccination
1. For individuals over age 50 who received the live zoster vaccine, protection against herpes zoster, postherpetic neuralgia, herpes zoster ...
